On hereditary ovarian cancer:Towards improved management of BRCA1/2 mutation carriers in opposite sides of the world by Teixeira, Natalia
  
 University of Groningen
On hereditary ovarian cancer
Teixeira, Natalia
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Teixeira, N. (2017). On hereditary ovarian cancer: Towards improved management of BRCA1/2 mutation
carriers in opposite sides of the world. [Groningen]: University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
1. The frequency of BRCA1/2 mutations in a consecutive cohort of Brazilian ovarian cancer 
patients is relatively high, emphasizing the relevance of investing on the implementation 
of genetic risk assessment of ovarian cancer patients in the public health care system in 
Brazil. – This thesis
2. Available algorithms for predicting BRCA1/2 mutation carrier risk, although still limited 
in their accuracy, could be used to reduce the number of patients to be referred for genetic 
testing substantially. These algorithms could be an important tool for the implementation 
of genetic risk assessment in areas with limited resources. – This thesis
3. The type of cancer family history is associated with ovarian cancer risks in BRCA1 
and BRCA2 mutation carriers. However this association is not strong enough to change 
counseling of BRCA1/2 mutation carriers regarding timely Risk Reducing Salpingo-
Oophorectomy. – This thesis
4. In BRCA1/2 mutation carriers, the previously reported effect of the mutation position on 
the gene on cancer risks may explain part, but not all of the impact of a cancer family 
history on ovarian cancer risk. – This thesis
5. Although women who had Risk Reducing Salpingo Oophorectomy at premenopausal 
age have an overall healthier life style when compared to age-matched women from 
the general population, they present a more atherogenic cholesterol profile, with higher 
serum levels of non-HDL cholesterol and lower serum levels of HDL cholesterol. – This 
thesis
6. Women who had surgical menopause have lower bone mineral density when compared to 
age-matched premenopausal women. However, when compared to natural menopause, 
surgical menopause has no evident impact on bone mineral density and on the prevalence 
of fractures. – This thesis
7. “Science knows no country, because knowledge belongs to humanity, and is the torch 
which illuminates the world.” – Louis Pasteur
8. “Nothing in life is to be feared, it is only to be understood. Now it is time to understand 
more, so that we may fear less.” – Marie Curie
9. “…to believe in medicine would be the height of folly, if not to believe in it were not 
greater folly still, for from this mass of errors there have emerged in the course of time 
many truths.” - Marcel Proust
Propositions
